EP2714735
Mótefni sem er sértæk fyrir TGF-beta
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.6.2012EP published:
21.7.2021EP application number:
12792320.9
EP translation filed:
19.10.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
31.5.2032Expiry date:
31.5.2025
Title:
ANTIBODIES SPECIFIC FOR TGF-BETA
Timeline
Today
1.6.2012EP application
21.7.2021EP Publication
19.10.2021Translation submitted
15.11.2021Registration published
31.5.2025Expires
Owner
Name:
XOMA Technology Ltd.Address:
XOMA Corporation 2910 Seventh Street, Berkeley, CA 94710, US
Inventor
Name:
BEDINGER, DanielAddress:
Berkeley, CA 94710, US
Name:
KHAN, Shireen, S.Address:
Berkeley, CA 94710, US
Name:
MIRZA, AmerAddress:
Berkeley, CA 94710, US
Name:
NARASIMHA, Ajay, J.Address:
Berkeley, CA 94710, US
Name:
TAKEUCHI, ToshihikoAddress:
Berkeley, CA 94710, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161493230 PDate:
3.6.2011Country:
US
Classification
Categories:
A61P 35/00, A61P 43/00, A61P 37/02, A61P 9/04, A61P 9/08, A61P 9/10, A61P 9/12, A61P 37/04, A61P 9/14, C07K 16/22
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 24.5.2022
Expires: 31.5.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.5.2023
Expires: 31.5.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.5.2024
Expires: 31.5.2025
Payer: Árnason Faktor ehf.